Asston Pharmaceuticals Ltd Peer Comparison
APL · Capital Goods · Current price ₹112.9
Peers tracked
11
Asston Pharmaceuticals Ltd P/E
22.9x
Sector
Capital Goods
Asston Pharmaceuticals Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,743 | 36.9x | 4,18,204 |
| DIVI S LABORATORIES LTD | ₹9,087 | 85.4x | 2,41,231 |
| TORRENT PHARMACEUTICALS L | ₹4,558.7 | 86.9x | 1,73,398 |
| LAURUS LABS LIMITED | ₹2,069 | 95.9x | 1,11,791 |
| ZYDUS LIFESCIENCES LTD | ₹1,113.9 | 24.3x | 1,11,112 |
| CIPLA LTD | ₹1,324.1 | 33.2x | 1,06,970 |
| DR. REDDY S LABORATORIES | ₹1,242.5 | 29.9x | 1,03,709 |
| AUROBINDO PHARMA LTD | ₹1,621.4 | 25.9x | 93,292 |
| MANKIND PHARMA LIMITED | ₹2,253.2 | 44.9x | 93,067 |
| LUPIN LIMITED | ₹1,939.2 | 17.1x | 88,678 |
| Asston Pharmaceuticals Ltd | — | 30.2x | 96 |
Asston Pharmaceuticals Ltd versus its peers
Asston Pharmaceuticals Ltd operates in the Capital Goods space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 22.9x may be cheap in one industry and expensive in another.
More on Asston Pharmaceuticals Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.